Physician Highlights Needs of People with CF in Congressional Roundtable

Dr. Frank Accurso, director of cystic fibrosis clinical research at Children's Hospital Colorado and University of Colorado Denver, participated in a congressional roundtable discussion at National Jewish Health in Denver, Colorado.

Sept. 4, 2014 | 2 min read

The roundtable discussion, hosted by Representative Diana DeGette (D-CO), focused on personalized medicine and its implications for research, drug development and patients. Dr. Accurso advocated for people with cystic fibrosis and suggested ways that Congress can support biomedical innovation and drug development. He emphasized the need for greater collaboration in drug discovery and development, the development of patient registries and clinical trial networks like those employed in the CF community and increased patient involvement in the process. He also urged policymakers to sustain increased funding for the NIH and the Food and Drug Administration (FDA).

Dr. Accurso and others pointed to Kalydeco, the first drug to treat the underlying cause of CF, as a great success story in personalized medicine. Kalydeco was approved in one of the fastest and most efficient FDA approval processes to date.

This event was held as part of the House of Representatives' “21st Century Cures” initiative. Co-sponsored by Rep. DeGette and House Energy and Commerce Committee Chair Fred Upton (R-MI), the initiative is focused on developing policies to accelerate the discovery, development and delivery of treatments and promote medical innovation. Robert J. Beall, Ph.D., president and CEO of the CF Foundation, also testified at a “21st Century Cures” hearing on patient participation in drug discovery and development in Washington, D.C., in July.

To learn more about the roundtable or the 21st Century Cures Initiative, visit

Share this article
About the CF Foundation | Public Policy | Research
Recent news
The CF Foundation’s 16th Annual Teen Advocacy Day Empowers Teens to Make Their Voice Heard
News | 4 min read
Cystic Fibrosis Community Perspectives Influence Future of CF Care Model
News | 4 min read
CF Foundation Adapts Registry Reporting to New Race-Neutral Standards
News | 5 min read
You might also be interested in...
Stay up to date with The Foundation

Sign up for our newsletter to get all of the latest news from The Foundation right in your inbox.